Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
about
Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response.Immunization with Streptococcus suis bacterin plus recombinant Sao protein in sows conveys passive immunity to their pigletsThe bias of experimental design, including strain background, in the determination of critical Streptococcus suis serotype 2 virulence factors.Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants.
P2860
Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protection against Streptococc ...... haride Glycoconjugate Vaccine.
@en
Protection against Streptococc ...... haride Glycoconjugate Vaccine.
@nl
type
label
Protection against Streptococc ...... haride Glycoconjugate Vaccine.
@en
Protection against Streptococc ...... haride Glycoconjugate Vaccine.
@nl
prefLabel
Protection against Streptococc ...... haride Glycoconjugate Vaccine.
@en
Protection against Streptococc ...... haride Glycoconjugate Vaccine.
@nl
P2093
P2860
P356
P1476
Protection against Streptococc ...... haride Glycoconjugate Vaccine.
@en
P2093
Axel Neubauer
Cynthia Calzas
Guillaume Goyette-Desjardins
Jennifer Kempker
Tze Chieh Shiao
P2860
P304
P356
10.1128/IAI.00139-16
P407
P577
2016-04-25T00:00:00Z